Brain and Psychological Diseases Department

【Department History】 The Department of Encephalopathy and Psychological Disorders was established in 1991. 【Department Honors】 It is currently a key specialty development unit of the National Administration of Traditional Chinese Medicine, a key TCM specialty in Guangdong Province and a key TCM specialty in Shenzhen. 【Department Leadership】 Professor Guo Zhouke was the founding department director and made outstanding contributions to the department's development. Since 2021, Professor Qin Xiude has served as the discipline leader and department director. 【Research Scope】 The department is dedicated to the TCM and Western medicine diagnosis and treatment, research and teaching of neuropsychological diseases including cerebrovascular disease, dementia, Parkinson's disease, myasthenia gravis, epilepsy, multiple sclerosis, depression, anxiety and sleep disorders. 【Department Services】 The department currently has 2 wards with 73 open beds, an electroencephalography room and a transcranial Doppler room. Its medical and nursing team has 44 members. The Encephalopathy and Psychological Disorders Department has 22 clinical physicians, including 8 psychotherapists, 1 famous TCM physician in Guangdong Province, 1 famous TCM physician in Shenzhen, 1 doctoral supervisor, 1 postdoctoral co-supervisor, 7 master's supervisors, 4 visiting scholars at renowned overseas universities, 2 chief physicians, 5 associate chief physicians, 2 postdoctoral fellows, 7 doctors, 2 doctoral students currently enrolled, 1 Shenzhen Municipal Health Commission Special Post B-level expert, 1 overseas Peacock C-category talent, 2 high-level talents in Shenzhen and 3 elite medical talents in Shenzhen. There are 22 nurses, including 10 chief/supervising nurses. The department sees more than 60,000 outpatient visits and more than 2,000 discharges annually. It operates 5 specialty clinics, including cerebrovascular disease, cognitive impairment and psychosomatic medicine. It has focused deeply on encephalopathy and psychological diseases. With support from Shenzhen's "Three Famous Projects" in medical and health care, it introduced the team of Academician Zhang Boli in 2021, which guided the development of a "TCM-Western medicine collaboration and integrated treatment of the mind and body" model, and established the Zhang Boli National Medical Master Heritage Studio. To promote the inheritance of academic thought from senior TCM physicians, the department established the Guangdong Famous TCM Physician Guo Zhouke Studio. It has developed through multi-platform collaboration, building a green stroke pathway and an integrated diagnosis and treatment system for psychosomatic medicine; clinical practice and research are deeply integrated, and it has conducted diagnostic and treatment optimization research jointly with the Evidence-Based Medicine Center of Tianjin University of Traditional Chinese Medicine. To fully leverage the advantages of TCM, the department has summarized and developed a set of TCM diagnosis and treatment protocols and effective specialty formulas and preparations over more than 30 years, such as Naosuikang Capsules, Tianxiong Tongluo Formula, Tianxiong Annai Formula and Shugan Yixin Formula. It uses intravenous thrombolysis and mechanical thrombectomy combined with Chinese medicines, acupuncture and other TCM therapies to build an "integrated TCM-Western medicine stroke unit," significantly improving patients' neurological function and reducing disability rates. In research, it has undertaken a total of 32 research projects of various types over the past five years, with research funding exceeding RMB 7.1 million, including 3 national-level projects, 7 provincial-level projects and 13 municipal-level projects. It has edited 2 monographs, obtained 6 national invention patents and developed 3 specialty diagnostic and treatment technologies for encephalopathy. Through continuous strengthening of discipline development, the specialty has formed an integrated service system of emergency stroke care, cognitive intervention and psychosomatic rehabilitation, and established a TCM-Western medicine integrated diagnosis and treatment model covering the entire disease cycle. Its clinical service and research innovation capabilities have improved significantly, giving it a clear advantage in the field of TCM encephalopathy in South China. In 2023, it passed dual accreditation as a national "Stroke Prevention and Treatment Center" and a "China Psychosomatic Medicine Integrated Diagnosis and Treatment Center." 【Department Group Photo】